• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 1997

View Archived Issues

Gd-Tex in phase Ib: safety profile and maximum tolerated dose

Read More

Novel class III antiarrhythmic agents described by Merck & Co.

Read More

Taisho reports new macrolides termed "acylides"

Read More

Nonexclusive licensing opportunity in HCV protease inhibitor research announced by Chiron

Read More

SDD drug delivery system available for licensing from Bioglan

Read More

SS-Cream evaluated in subjects with premature ejaculation

Read More

Safety and efficacy data for INVICORP reported at impotence meeting

Read More

MOMP DNA immunization for chlamydial infections

Read More

Efficacy of cholesterol biosynthesis inhibitor demonstrated in dogs

Read More

GS-4104 (Ro-64-0796): safety and pharmacokinetics in humans

Read More

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Read More

Clinical pharmacokinetic study of panomifene described

Read More

BB-2983 development discontinued

Read More

Behring Diagnostics-Dade merger complete

Read More

Profile of a monobactam beta-lactamase inhibitor

Read More

Block Drug to promote Duract to U.S. dentists

Read More

Kyowa Hakko's cytostatic agents progress in U.S. clinical trials

Read More

Korean research institute synthesizes potent DNA gyrase inhibitors

Read More

Rhone-Poulenc completes tender offer for Rhone-Poulenc Rorer

Read More

Celgene initiates clinical trials for novel TNF-alpha inhibitors

Read More

Guilford issued U.S. patent on NAALADase inhibitors

Read More

New antifungal antibiotic with sphingosine-like lipid moiety

Read More

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Read More

Abbott prepares and evaluates tetracyclic ketolides as antibacterials

Read More

Mitsui Toatsu's hGH enters clinical testing this month

Read More

Genentech returns rights to IDEC-Y2B8 to IDEC

Read More

Spine-Tech and Sulzer Orthopedics Biologics announce alliance

Read More

Asahi Chemical's AP-521 in clinical development in three countries

Read More

Nasonex Nasal Spray cleared for marketing in U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe